Prognostic determinants for long term outcome of low grade follicular lymphomas after cytoreductive chemotherapy and interferon alpha maintenance. Results of the German Low Grade Lymphoma Study Group (GLSG).

被引：0
|
作者：
Unterhalt, M [1 ]
Hermann, R [1 ]
Koch, P [1 ]
Trumper, L [1 ]
Bodenstein, H [1 ]
Dietzfelbinger, H [1 ]
Landys, K [1 ]
Reuss, M [1 ]
Vetter, H [1 ]
Maschmeyer, G [1 ]
Freund, M [1 ]
Neubauer, A [1 ]
Engert, A [1 ]
Stauder, R [1 ]
Herold, M [1 ]
Tiemann, M [1 ]
Parwaresch, R [1 ]
Stein, H [1 ]
Hiddemann, W [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1743 / 1743
页数：1
相关论文
共 50 条
  • [1] Interferon maintenance prolongs remission duration after retrospective analysis of the German Low-Grade Lymphoma Study Group (GLSG)
    Hoster, E.
    Unterhalt, M.
    Forstpointner, R.
    Pfreundschuh, M.
    Hallek, M.
    Kneba, M.
    Lengfelder, E.
    Metzner, B.
    Wandt, H.
    Dreyling, M.
    Hiddemann, W.
    ONKOLOGIE, 2011, 34 : 99 - 99
  • [2] Long term interferon alpha maintenance prolongs remission duration in advanced low grade lymphomas and is related to the efficacy of initial cytoreductive chemotherapy
    Unterhalt, M
    Hermann, R
    Koch, P
    Trumper, L
    Bodenstein, H
    Dietzfelbinger, H
    Landys, K
    Reuss, M
    Vetter, H
    Maschmeyer, G
    Freund, M
    Neubauer, A
    Engert, A
    Stauder, R
    Herold, M
    Tiemann, M
    Parwaresch, R
    Stein, H
    Hiddemann, W
    BLOOD, 1996, 88 (10) : 1801 - 1801
  • [3] Rituximab maintenance after R-FCM salvage therapy in patients with follicular and mantle cell lymphomas - Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)
    Unterhalt, M.
    Forstpointner, R.
    Dreyling, M.
    Gramatzki, M.
    Bock, H. P.
    Hanel, Annette
    Seymour, J.
    Planker, M.
    Duhrsen, U.
    Wilms, K.
    Clemens, M.
    Ludwig, W. D.
    Wandt, H.
    Pasold, R.
    Hiddemann, W.
    ANNALS OF HEMATOLOGY, 2006, 85 : 36 - 37
  • [4] Rituximab maintenance following a rituximab containing chemotherapy significantly prolongs the duration of response in patients with relapsed follicular and mantle cell lymphomas:: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Hiddeman, W
    Forstpointner, R
    Dreyling, M
    Gramatzki, M
    Böck, HP
    Haenel, M
    Seymour, JF
    Unterhalt, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 566S - 566S
  • [5] Rituximab maintenance prolongs response duration after salvage therapy with R-FCM in patients with relapsed follicular lymphomas and mantle cell lymphomas:: Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
    Hiddemann, W
    Forstpointner, R
    Dreyling, M
    Gramatzki, M
    Böck, HP
    Hanel, M
    Seymour, J
    Planker, M
    Dührsen, U
    Wilms, K
    Clemens, M
    Ludwig, WD
    Wandt, H
    Pasold, R
    Unterhalt, M
    BLOOD, 2005, 106 (11) : 270A - 270A
  • [6] Myeloablative radiochemotherapy followed by blood-stemcell-transplantation significantly prolongs the disease-free interval in patients with low-grade lymphomas as compared to standard maintenance with interferon alpha:: Results of a prospective randomized comparison by the German low grade lymphoma study group (GLSG).
    Hiddemann, W
    Unterhalt, M
    Wandt, H
    Huber, C
    Dörken, B
    Kuse, R
    Pfeundschuh, M
    Parwaresch, R
    BLOOD, 1999, 94 (10) : 610A - 611A
  • [7] ALPHA-INTERFERON MAINTENANCE THERAPY IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMAS AFTER CYTOREDUCTIVE CHEMOTHERAPY WITH PREDNIMUSTINE AND MITOXANTRONE
    HIDDEMANN, W
    UNTERHALT, M
    KOCH, P
    NAHLER, M
    HERRMANN, R
    VANDELOO, J
    EUROPEAN JOURNAL OF CANCER, 1991, 27 : S37 - S39
  • [8] Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
    Schmidt, Christian
    Zoellner, Anna-Katharina
    Jurinovic, Vindi
    Soekler, Martin
    Forstpointner, Roswitha
    Haubner, Sascha
    Buske, Christian
    Viardot, Andreas
    Keller, Ulrich
    Pott, Christiane
    Graeven, Ullrich
    Marks, Reinhard
    Haenel, Mathias
    Liersch, Ruediger
    Duerig, Jan
    Hoster, Eva
    Unterhalt, Michael
    Hiddemann, Wolfgang
    BLOOD, 2018, 132
  • [9] CHOP improves response rates but not overall survival in follicular and mantle cell lymphoma (MCL) -: Results of a randomized trial of the German Low Grade Lymphoma Study Group (GLSG)
    Nickenig, C
    Dreyling, MH
    Schiegnitz, E
    Pfreundschuh, M
    Truemper, LH
    Reiser, M
    Wandt, H
    Lengfelder, E
    Ludwig, WD
    Berdel, WE
    Metzner, B
    Hess, G
    Forstpointner, R
    Parwaresch, R
    Hasford, J
    Unterhalt, M
    Hiddemann, W
    BLOOD, 2004, 104 (11) : 176A - 176A
  • [10] Interferon Maintenance Prolongs Remission Duration After Rituximab-Containing Induction In First-Line Advanced Stage Follicular Lymphoma Patients - a Retrospective Analysis of the German Low-Grade Lymphoma Study Group (GLSG)
    Unterhalt, Michael
    Hoster, Eva
    Dreyling, Martin H.
    Hiddemann, Wolfgang
    BLOOD, 2010, 116 (21) : 1179 - 1179
12345